186 related articles for article (PubMed ID: 17681491)
1. Stem cells as screening tools in drug discovery.
McNeish JD
Curr Opin Pharmacol; 2007 Oct; 7(5):515-20. PubMed ID: 17681491
[TBL] [Abstract][Full Text] [Related]
2. Pluripotent human stem cells as novel tools in drug discovery and toxicity testing.
Sartipy P; Bjorquist P; Strehl R; Hyllner J
IDrugs; 2006 Oct; 9(10):702-5. PubMed ID: 17016777
[TBL] [Abstract][Full Text] [Related]
3. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
4. Human cell systems for drug discovery.
Horrocks C; Halse R; Suzuki R; Shepherd PR
Curr Opin Drug Discov Devel; 2003 Jul; 6(4):570-5. PubMed ID: 12951820
[TBL] [Abstract][Full Text] [Related]
5. From targets to leads: the importance of advanced data analysis for decision support in drug discovery.
Fischer HP; Heyse S
Curr Opin Drug Discov Devel; 2005 May; 8(3):334-46. PubMed ID: 15892249
[TBL] [Abstract][Full Text] [Related]
6. Stem cells in drug discovery, tissue engineering, and regenerative medicine: emerging opportunities and challenges.
Nirmalanandhan VS; Sittampalam GS
J Biomol Screen; 2009 Aug; 14(7):755-68. PubMed ID: 19675315
[TBL] [Abstract][Full Text] [Related]
7. The application of human embryonic stem cell technologies to drug discovery.
Sartipy P; Björquist P; Strehl R; Hyllner J
Drug Discov Today; 2007 Sep; 12(17-18):688-99. PubMed ID: 17826681
[TBL] [Abstract][Full Text] [Related]
8. Regulation of 'stemness' and stem cell differentiation by microRNAs.
Sartipy P; Olsson B; Hyllner J; Synnergren J
IDrugs; 2009 Aug; 12(8):492-6. PubMed ID: 19629883
[TBL] [Abstract][Full Text] [Related]
9. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
10. Impact of drug discovery on stem cell biology.
Zhang XZ; Li XJ; Ji HF; Zhang HY
Biochem Biophys Res Commun; 2009 Jun; 383(3):275-9. PubMed ID: 19366619
[TBL] [Abstract][Full Text] [Related]
11. Human stem cells for modeling neurological disorders: accelerating the drug discovery pipeline.
Crook JM; Kobayashi NR
J Cell Biochem; 2008 Dec; 105(6):1361-6. PubMed ID: 18980214
[TBL] [Abstract][Full Text] [Related]
12. Seeding drug discovery: integrating telomerase cancer biology and cellular senescence to uncover new therapeutic opportunities in targeting cancer stem cells.
Keith WN; Thomson CM; Howcroft J; Maitland NJ; Shay JW
Drug Discov Today; 2007 Aug; 12(15-16):611-21. PubMed ID: 17706542
[TBL] [Abstract][Full Text] [Related]
13. Can human embryonic stem cells contribute to the discovery of safer and more effective drugs?
Cezar GG
Curr Opin Chem Biol; 2007 Aug; 11(4):405-9. PubMed ID: 17662644
[TBL] [Abstract][Full Text] [Related]
14. Understanding mechanisms of toxicity: insights from drug discovery research.
Houck KA; Kavlock RJ
Toxicol Appl Pharmacol; 2008 Mar; 227(2):163-78. PubMed ID: 18063003
[TBL] [Abstract][Full Text] [Related]
15. Human embryonic stem cell technologies and drug discovery.
Jensen J; Hyllner J; Björquist P
J Cell Physiol; 2009 Jun; 219(3):513-9. PubMed ID: 19277978
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.
Braam SR; Passier R; Mummery CL
Trends Pharmacol Sci; 2009 Oct; 30(10):536-45. PubMed ID: 19762090
[TBL] [Abstract][Full Text] [Related]
17. Challenges of high throughput screening against cell surface receptors.
Major JS
J Recept Signal Transduct Res; 1995; 15(1-4):595-607. PubMed ID: 8903966
[TBL] [Abstract][Full Text] [Related]
18. The impact of diversity-based, high-throughput screening on drug discovery: "chance favours the prepared mind".
Snowden M; Green DV
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):553-8. PubMed ID: 18600571
[TBL] [Abstract][Full Text] [Related]
19. High content screening: seeing is believing.
Zanella F; Lorens JB; Link W
Trends Biotechnol; 2010 May; 28(5):237-45. PubMed ID: 20346526
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery.
Steel D; Hyllner J; Sartipy P
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):133-40. PubMed ID: 19152222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
